SNP and Phylogenetic Characterization of Low Viral Load SARS-CoV-2 Specimens by Target Enrichment

被引:6
作者
Orf, Gregory S. [1 ]
Forberg, Kenn [1 ]
Meyer, Todd V. [1 ]
Mowerman, Illya [1 ]
Mohaimani, Aurash [1 ]
Faron, Matthew L. [2 ]
Jennings, Cheryl [3 ]
Landay, Alan L. [3 ]
Goldstein, D. Yitz [4 ]
Fox, Amy S. [4 ]
Berg, Michael G. [1 ]
Cloherty, Gavin A. [1 ]
机构
[1] Abbott Labs, Abbott Diag Div, Infect Dis Res, Abbott Pk, IL 60064 USA
[2] Med Coll Wisconsin, Milwaukee, WI USA
[3] Rush Univ, Med Ctr, Chicago, IL USA
[4] Albert Einstein Coll Med, Montefiore Med Ctr, Bronx, NY USA
来源
FRONTIERS IN VIROLOGY | 2021年 / 1卷
关键词
next generation (deep) sequencing (NGS); target enrichment; SARS-CoV-2; xGen; coronavirus-COVID-19; COVID-19; ACCURATE;
D O I
10.3389/fviro.2021.765974
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Surveillance of SARS-CoV-2 across the globe has enabled detection of new variants and informed the public health response. With highly sensitive methods like qPCR widely adopted for diagnosis, the ability to sequence and characterize specimens with low titers needs to keep pace.Methods: Nucleic acids extracted from nasopharyngeal swabs collected from four sites in the United States in early 2020 were converted to NGS libraries to sequence SARS-CoV-2 genomes using metagenomic and xGen target enrichment approaches. Single nucleotide polymorphism (SNP) analysis and phylogeny were used to determine clade assignments and geographic origins of strains.Results: SARS-CoV-2-specific xGen enrichment enabled full genome coverage for 87 specimens with Ct values <29, corresponding to viral loads of >10,000 cp/ml. For samples with viral loads between 103 and 106 cp/ml, the median genome coverage for xGen was 99.1%, sequence depth was 605X, and the "on-target" rate was 57 +/- 21%, compared to 13%, 2X and 0.001 +/- 0.016%, respectively, for metagenomic sequencing alone. Phylogenetic analysis revealed the presence of most clades that existed at the time of the study, though clade GH dominated in the Midwest.Conclusions: Even as vaccines are being widely distributed, a high case load of SARS-CoV-2 infection persists around the world. Viral genetic surveillance has succeeded in warning the public of new variants in circulation and ensured that diagnostic tools remain resilient to a steadily increasing number of mutations. Target capture offers a means of characterizing low viral load samples which would normally pose a challenge for metagenomic sequencing.
引用
收藏
页数:12
相关论文
共 45 条
[1]  
Abbott Molecular., 2020, Abbott Real Time SARS-CoV-2 Assay
[2]   Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative [J].
Anisimova, Maria ;
Gascuel, Olivier .
SYSTEMATIC BIOLOGY, 2006, 55 (04) :539-552
[3]   Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity [J].
Berg, Michael G. ;
Zhen, Wei ;
Lucic, Danijela ;
Degli-Angeli, Emily J. ;
Anderson, Mark ;
Forberg, Kenn ;
Olivo, Ana ;
Sheikh, Farah ;
Toolsie, Dan ;
Greninger, Alexander L. ;
Cloherty, Gavin A. ;
Coombs, Robert W. ;
Berry, Gregory J. .
JOURNAL OF CLINICAL VIROLOGY, 2021, 143
[4]   Advanced molecular surveillance approaches for characterization of blood borne hepatitis viruses [J].
Berg, Michael G. ;
Olivo, Ana ;
Forberg, Kenn ;
Harris, Barbara J. ;
Yamaguchi, Julie ;
Shirazi, Rachel ;
Gozlan, Yael ;
Sauleda, Silvia ;
Kaptue, Lazare ;
Rodgers, Mary A. ;
Mor, Orna ;
Cloherty, Gavin A. .
PLOS ONE, 2020, 15 (07)
[5]  
Bonsall David, 2015, F1000Res, V4, P1062, DOI 10.12688/f1000research.7111.1
[6]   Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients [J].
Buchan, Blake W. ;
Hoff, Jessica S. ;
Gmehlin, Cameron G. ;
Perez, Adriana ;
Faron, Matthew L. ;
Munoz-Price, L. Silvia ;
Ledeboer, Nathan A. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 (04) :479-485
[7]   Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States [J].
Kujawski S.A. ;
Wong K.K. ;
Collins J.P. ;
Epstein L. ;
Killerby M.E. ;
Midgley C.M. ;
Abedi G.R. ;
Ahmed N.S. ;
Almendares O. ;
Alvarez F.N. ;
Anderson K.N. ;
Balter S. ;
Barry V. ;
Bartlett K. ;
Beer K. ;
Ben-Aderet M.A. ;
Benowitz I. ;
Biggs H.M. ;
Binder A.M. ;
Black S.R. ;
Bonin B. ;
Bozio C.H. ;
Brown C.M. ;
Bruce H. ;
Bryant-Genevier J. ;
Budd A. ;
Buell D. ;
Bystritsky R. ;
Cates J. ;
Charles E.M. ;
Chatham-Stephens K. ;
Chea N. ;
Chiou H. ;
Christiansen D. ;
Chu V. ;
Cody S. ;
Cohen M. ;
Conners E.E. ;
Curns A.T. ;
Dasari V. ;
Dawson P. ;
DeSalvo T. ;
Diaz G. ;
Donahue M. ;
Donovan S. ;
Duca L.M. ;
Erickson K. ;
Esona M.D. ;
Evans S. ;
Falk J. .
NATURE MEDICINE, 2020, 26 (06) :861-+
[8]   Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England [J].
Davies, Nicholas G. ;
Abbott, Sam ;
Barnard, Rosanna C. ;
Jarvis, Christopher, I ;
Kucharski, Adam J. ;
Munday, James D. ;
Pearson, Carl A. B. ;
Russell, Timothy W. ;
Tully, Damien C. ;
Washburne, Alex D. ;
Wenseleers, Tom ;
Gimma, Amy ;
Waites, William ;
Wong, Kerry L. M. ;
van Zandvoort, Kevin ;
Silverman, Justin D. ;
Diaz-Ordaz, Karla ;
Keogh, Ruth ;
Eggo, Rosalind M. ;
Funk, Sebastian ;
Jit, Mark ;
Atkins, Katherine E. ;
Edmunds, W. John .
SCIENCE, 2021, 372 (6538) :149-+
[9]   Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance [J].
Degli-Angeli, Emily ;
Dragavon, Joan ;
Huang, Meei-Li ;
Lucic, Danijela ;
Cloherty, Gavin ;
Jerome, Keith R. ;
Greninger, Alexander L. ;
Coombs, Robert W. .
JOURNAL OF CLINICAL VIROLOGY, 2020, 129
[10]   UFBoot2: Improving the Ultrafast Bootstrap Approximation [J].
Diep Thi Hoang ;
Chernomor, Olga ;
von Haeseler, Arndt ;
Minh, Bui Quang ;
Le Sy Vinh .
MOLECULAR BIOLOGY AND EVOLUTION, 2018, 35 (02) :518-522